How NHS collaboration with the pharma industry could benefit both players

A meeting underway with hands pointing at graph data

The challenge to find cost-savings while innovating services presents issues for both the NHS and the pharmaceutical industry to address, but an opportunity to collaborate could bring them closer together for the benefit of all. PA Consulting Group colleagues Dr Stephen Black and Ian Rhodes explain.

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Enquire about multi-user access